Ireland
--:--IST
Starting soon Not applicable

Clinical Outcomes of Sedation in Cataract Surgery Performed Under Topical Anesthesia

NCT07347886 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01
Last updated
2026-01-16

Condition(s) studied

Cataract

Investigational drug(s) / intervention(s)

Normal SalineMidalozam →Fentanyl (IV) →

Normal Saline: Intravenous normal saline administered in an identical volume as placebo to maintain blinding. No sedative or opioid medication will be given.

Midalozam: Intravenous midazolam administered for procedural sedation during cataract surgery performed under topical anesthesia. The medication will be prepared and administered in standardized doses and identical volumes to maintain blinding.

Fentanyl (IV): intravenous fentanyl administered in combination with midazolam to provide analgesia and sedation during cataract surgery under topical anesthesia. The medication will be prepared and administered in standardized doses and equal volumes to ensure blinding across study groups.

Study summary

This study aims to evaluate the clinical outcomes of different sedation strategies in patients undergoing cataract surgery performed under topical anesthesia. Cataract surgery is commonly performed under topical anesthesia; however, some patients may experience anxiety, discomfort, or inadequate cooperation during the procedure. Sedation may improve patient comfort and surgical conditions, but it may also be associated with potential adverse effects.

In this randomized, prospective study, patients will be assigned to one of three groups: topical anesthesia alone, topical anesthesia combined with midazolam, or topical anesthesia combined with midazolam and fentanyl. Intraoperative sedation levels, hemodynamic parameters, patient satisfaction, and surgeon satisfaction will be assessed and compared among the groups.

The results of this study are expected to provide evidence regarding the effectiveness and safety of sedation during cataract surgery performed under topical anesthesia and to help optimize perioperative sedation strategies for these patients.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥ 50 years * American Society of Anesthesiologists (ASA) physical status I-III * Patients scheduled for elective unilateral cataract surgery * Surgery planned to be performed under topical anesthesia * Ability to understand the study procedures and provide written informed consent after being fully informed about the study Exclusion Criteria: * Refusal to participate in the study or withdrawal of consent at any stage of the study * Known intolerance or contraindication to sedative and/or opioid medications * Presence of significant cardiac arrhythmias * Severe chronic obstructive pulmonary disease (COPD) * Hepatic or renal failure * Inability to cooperate due to cognitive impairment or hearing disability * Opioid dependence * Diagnosis of obstructive sleep apnea syndrome (OSAS) * New York Heart Association (NYHA) class III-IV heart failure * Conversion to general anesthesia for any reason during surgery

Primary outcome measure(s)

  • Patient satisfaction after cataract surgery — 1 hour postoperatively
    Patient satisfaction will be assessed using the validated Turkish version of the Iowa Satisfaction with Anesthesia Scale (ISAS-T). The ISAS-T total score will be calculated according to the instrument instructions; higher scores indicate greater satisfaction.

Trial sites (1)

FacilityCityRegionStatus
Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine Istanbul Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07347886 on ClinicalTrials.gov ↗ ← All trials in Turkey